Selected research
Industry Research
Leucine Industry Research Report 2026
Market perspective
The global Leucine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Leucine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Leucine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Leucine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Leucine include Ajinomoto Group, Evonik, CJ, KYOWA, Hubei Bafeng Pharmaceutical, Jinghai Amino Acid, JIRONG PHARM, Jiahe Biotech and ChuyuanGroup, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Leucine market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Leucine Market by Company
Ajinomoto Group
Evonik
CJ
KYOWA
Hubei Bafeng Pharmaceutical
Jinghai Amino Acid
JIRONG PHARM
Jiahe Biotech
ChuyuanGroup
Siwei Amino Acid
SHINE STAR（HUBEI）BLOLOGICAL
JiangsuShenhua Pharmaceutical
ZhangjiagangxingyuTechnology
Leucine Segment by Type
Food Grade
Feed Grade
Pharmaceutical Grade
Leucine Segment by Application
Food
Feed
Pharmaceuticals
Leucine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leucine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Leucine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leucine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Leucine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Leucine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Leucine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Feed Grade
- Pharmaceutical Grade
Applications
- Food
- Feed
- Pharmaceuticals
Companies covered
- Ajinomoto Group
- Evonik
- CJ
- KYOWA
- Hubei Bafeng Pharmaceutical
- Jinghai Amino Acid
- JIRONG PHARM
- Jiahe Biotech
- ChuyuanGroup
- Siwei Amino Acid
- SHINE STAR（HUBEI）BLOLOGICAL
- JiangsuShenhua Pharmaceutical
- ZhangjiagangxingyuTechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Leucine Market Size (2021-2032)
- 2.2.2 Global Leucine Sales (2021-2032)
- 2.2.3 Global Leucine Market Average Price (2021-2032)
- 2.3 Leucine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food Grade
- 2.3.3 Feed Grade
- 2.3.4 Pharmaceutical Grade
- 2.4 Leucine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food
- 2.4.3 Feed
- 2.4.4 Pharmaceuticals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Leucine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Leucine Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Leucine Revenue of Manufacturers (2021-2026)
- 3.4 Global Leucine Average Price by Manufacturers (2021-2026)
- 3.5 Global Leucine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Leucine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Leucine, Product Type & Application
- 3.8 Global Manufacturers of Leucine, Established Date
- 3.9 Global Leucine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ajinomoto Group
- 4.1.1 Ajinomoto Group Company Information
- 4.1.2 Ajinomoto Group Business Overview
- 4.1.3 Ajinomoto Group Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ajinomoto Group Leucine Product Portfolio
- 4.1.5 Ajinomoto Group Recent Developments
- 4.2 Evonik
- 4.2.1 Evonik Company Information
- 4.2.2 Evonik Business Overview
- 4.2.3 Evonik Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Evonik Leucine Product Portfolio
- 4.2.5 Evonik Recent Developments
- 4.3 CJ
- 4.3.1 CJ Company Information
- 4.3.2 CJ Business Overview
- 4.3.3 CJ Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CJ Leucine Product Portfolio
- 4.3.5 CJ Recent Developments
- 4.4 KYOWA
- 4.4.1 KYOWA Company Information
- 4.4.2 KYOWA Business Overview
- 4.4.3 KYOWA Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 KYOWA Leucine Product Portfolio
- 4.4.5 KYOWA Recent Developments
- 4.5 Hubei Bafeng Pharmaceutical
- 4.5.1 Hubei Bafeng Pharmaceutical Company Information
- 4.5.2 Hubei Bafeng Pharmaceutical Business Overview
- 4.5.3 Hubei Bafeng Pharmaceutical Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hubei Bafeng Pharmaceutical Leucine Product Portfolio
- 4.5.5 Hubei Bafeng Pharmaceutical Recent Developments
- 4.6 Jinghai Amino Acid
- 4.6.1 Jinghai Amino Acid Company Information
- 4.6.2 Jinghai Amino Acid Business Overview
- 4.6.3 Jinghai Amino Acid Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jinghai Amino Acid Leucine Product Portfolio
- 4.6.5 Jinghai Amino Acid Recent Developments
- 4.7 JIRONG PHARM
- 4.7.1 JIRONG PHARM Company Information
- 4.7.2 JIRONG PHARM Business Overview
- 4.7.3 JIRONG PHARM Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 JIRONG PHARM Leucine Product Portfolio
- 4.7.5 JIRONG PHARM Recent Developments
- 4.8 Jiahe Biotech
- 4.8.1 Jiahe Biotech Company Information
- 4.8.2 Jiahe Biotech Business Overview
- 4.8.3 Jiahe Biotech Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiahe Biotech Leucine Product Portfolio
- 4.8.5 Jiahe Biotech Recent Developments
- 4.9 ChuyuanGroup
- 4.9.1 ChuyuanGroup Company Information
- 4.9.2 ChuyuanGroup Business Overview
- 4.9.3 ChuyuanGroup Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ChuyuanGroup Leucine Product Portfolio
- 4.9.5 ChuyuanGroup Recent Developments
- 4.10 Siwei Amino Acid
- 4.10.1 Siwei Amino Acid Company Information
- 4.10.2 Siwei Amino Acid Business Overview
- 4.10.3 Siwei Amino Acid Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Siwei Amino Acid Leucine Product Portfolio
- 4.10.5 Siwei Amino Acid Recent Developments
- 4.11 SHINE STAR（HUBEI）BLOLOGICAL
- 4.11.1 SHINE STAR（HUBEI）BLOLOGICAL Company Information
- 4.11.2 SHINE STAR（HUBEI）BLOLOGICAL Business Overview
- 4.11.3 SHINE STAR（HUBEI）BLOLOGICAL Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SHINE STAR（HUBEI）BLOLOGICAL Leucine Product Portfolio
- 4.11.5 SHINE STAR（HUBEI）BLOLOGICAL Recent Developments
- 4.12 JiangsuShenhua Pharmaceutical
- 4.12.1 JiangsuShenhua Pharmaceutical Company Information
- 4.12.2 JiangsuShenhua Pharmaceutical Business Overview
- 4.12.3 JiangsuShenhua Pharmaceutical Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 JiangsuShenhua Pharmaceutical Leucine Product Portfolio
- 4.12.5 JiangsuShenhua Pharmaceutical Recent Developments
- 4.13 ZhangjiagangxingyuTechnology
- 4.13.1 ZhangjiagangxingyuTechnology Company Information
- 4.13.2 ZhangjiagangxingyuTechnology Business Overview
- 4.13.3 ZhangjiagangxingyuTechnology Leucine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ZhangjiagangxingyuTechnology Leucine Product Portfolio
- 4.13.5 ZhangjiagangxingyuTechnology Recent Developments
5 Global Leucine Market Scenario by Region
- 5.1 Global Leucine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Leucine Sales by Region: 2021-2032
- 5.2.1 Global Leucine Sales by Region: 2021-2026
- 5.2.2 Global Leucine Sales by Region: 2027-2032
- 5.3 Global Leucine Revenue by Region: 2021-2032
- 5.3.1 Global Leucine Revenue by Region: 2021-2026
- 5.3.2 Global Leucine Revenue by Region: 2027-2032
- 5.4 North America Leucine Market Facts & Figures by Country
- 5.4.1 North America Leucine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Leucine Sales by Country (2021-2032)
- 5.4.3 North America Leucine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Leucine Market Facts & Figures by Country
- 5.5.1 Europe Leucine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Leucine Sales by Country (2021-2032)
- 5.5.3 Europe Leucine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Leucine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Leucine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Leucine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Leucine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Leucine Market Facts & Figures by Country
- 5.7.1 South America Leucine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Leucine Sales by Country (2021-2032)
- 5.7.3 South America Leucine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Leucine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Leucine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Leucine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Leucine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Leucine Sales by Type (2021-2032)
- 6.1.1 Global Leucine Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Leucine Sales Market Share by Type (2021-2032)
- 6.2 Global Leucine Revenue by Type (2021-2032)
- 6.2.1 Global Leucine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Leucine Revenue Market Share by Type (2021-2032)
- 6.3 Global Leucine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Leucine Sales by Application (2021-2032)
- 7.1.1 Global Leucine Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Leucine Sales Market Share by Application (2021-2032)
- 7.2 Global Leucine Revenue by Application (2021-2032)
- 7.2.1 Global Leucine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Leucine Revenue Market Share by Application (2021-2032)
- 7.3 Global Leucine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Leucine Value Chain Analysis
- 8.1.1 Leucine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Leucine Production Mode & Process
- 8.2 Leucine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Leucine Distributors
- 8.2.3 Leucine Customers
9 Global Leucine Analyzing Market Dynamics
- 9.1 Leucine Industry Trends
- 9.2 Leucine Industry Drivers
- 9.3 Leucine Industry Opportunities and Challenges
- 9.4 Leucine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst